Literature DB >> 17664371

Patent foramen ovale closure by radiofrequency thermal coaptation: first experience in the porcine model and healing mechanisms over time.

Hidehiko Hara1, Thomas K Jones, Elena R Ladich, Renu Virmani, David C Auth, Joseph E Eichinger, Robert J Sommer, Robert A Van Tassel, Robert S Schwartz.   

Abstract

BACKGROUND: Percutaneous transcatheter patent foramen ovale (PFO) closure is now standard practice and may limit embolic complications for at least 10 years. Implantable PFO closure devices may be complicated by thrombosis, infection, device fracture, or embolization. A novel strategy uses radiofrequency-based thermal energy to seal PFO membranes, with no implanted device. We successfully used this method and examined histopathologic events in swine to characterize safety and efficacy. METHODS AND
RESULTS: Thirteen domestic swine were examined over time after thermal PFO closure. Three animals were euthanized within 1 hour of treatment, 5 after 7 days, and 5 at 28 days. Gross and histopathologic findings were examined. Radiofrequency energy was delivered successfully in all cases, and PFOs were closed in 12 of 13 cases. One case was not suitable for histological examination because of laceration at euthanasia, and the other PFO was clinically closed, with no shunt at 7 days, but was histologically open. All of the other PFOs were confirmed closed histologically. Acute histological results showed edema, hemorrhage, and myocyte necrosis. Minimal thrombus formation occurred on the left atrial endocardial surface. At day 7, transmural thermal effects occurred through the atrial wall that extended to the epicardial surface. At day 28, thermal effects showed excellent scar formation. Collagen, matrix, and neovascularization were present in all cases. No animal experienced adverse events.
CONCLUSIONS: Thermal PFO closure is feasible, safe, and effective in swine. Thermal healing is nearly complete by 4 weeks and consists of collagen formation and tunnel closure. This technique may allow substantial reduction in PFO closure risk over current device-based therapy.

Entities:  

Mesh:

Year:  2007        PMID: 17664371     DOI: 10.1161/CIRCULATIONAHA.107.697276

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  4 in total

Review 1.  Percutaneous interventions in adults with congenital heart disease: expanding indications and opportunities.

Authors:  Stéphane Noble; Réda Ibrahim
Journal:  Curr Cardiol Rep       Date:  2009-07       Impact factor: 2.931

Review 2.  State-of-the-Art Atrial Septal Defect Closure Devices for Congenital Heart.

Authors:  Michael L O'Byrne; Daniel S Levi
Journal:  Interv Cardiol Clin       Date:  2019-01

3.  Closure of foramen ovale triggered by injury to tunnel surfaces of septum primum and secundum.

Authors:  Luigi Di Biase; J David Burkhardt; Rodney Horton; Javier Sanchez; Prasant Mohanty; Sanghamitra Mohanty; Shane Bailey; G Joseph Gallinghouse; Andrea Natale; Subramaniam C Krishnan
Journal:  J Interv Card Electrophysiol       Date:  2019-01-31       Impact factor: 1.900

Review 4.  Patent foramen ovale closure. Pro and cons.

Authors:  Eustaquio Onorato; Francesco Casilli; Marco Berti; Gian Paolo Anzola
Journal:  Neurol Sci       Date:  2008-05       Impact factor: 3.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.